Impact of primary staging with fibroblast activation protein specific enzyme inhibitor (FAPI)-PET/CT on radio-oncologic treatment planning of patients with esophageal cancer

Quinoline-based ligands targeting cancer-associated fibroblasts have emerged as promising radiopharmaceuticals in different tumor entities. The aim of this retrospective study was to explore the potential of FAPI-PET/CT in the initial staging of esophageal cancer patients and its usefulness in radio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ristau, Jonas (VerfasserIn) , Giesel, Frederik L. (VerfasserIn) , Häfner, Matthias (VerfasserIn) , Staudinger, Fabian (VerfasserIn) , Lindner, Thomas (VerfasserIn) , Merkel, Andreas (VerfasserIn) , Schlittenhardt, Joel (VerfasserIn) , Kratochwil, Clemens (VerfasserIn) , Choyke, P. L. (VerfasserIn) , Herfarth, Klaus (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Körber, Stefan A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 5 October 2020
In: Molecular imaging & biology
Year: 2020, Jahrgang: 22, Heft: 6, Pages: 1495-1500
ISSN:1860-2002
DOI:10.1007/s11307-020-01548-y
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11307-020-01548-y
Volltext
Verfasserangaben:J. Ristau, F.L. Giesel, M.F. Haefner, F. Staudinger, T. Lindner, A. Merkel, J. Schlittenhardt, C. Kratochwil, P.L. Choyke, K. Herfarth, J. Debus, U. Haberkorn, S.A. Koerber
Beschreibung
Zusammenfassung:Quinoline-based ligands targeting cancer-associated fibroblasts have emerged as promising radiopharmaceuticals in different tumor entities. The aim of this retrospective study was to explore the potential of FAPI-PET/CT in the initial staging of esophageal cancer patients and its usefulness in radiotherapy planning as a first clinical analysis.
Beschreibung:Gesehen am 18.10.2021
Beschreibung:Online Resource
ISSN:1860-2002
DOI:10.1007/s11307-020-01548-y